Sirdás sisdollui
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aiddostahtton
  • Effectiveness of glecaprevir/p...
  • Čujuhandieđut
  • Deakstadieđáhus
  • Sádde šleađgaboasttain
  • Čálit
  • Doalvvo čujuhusa
    • Doalvun: RefWorks
    • Doalvun: EndNoteWeb
    • Doalvun: EndNote
  • Bissovaš liŋka
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

Bibliográfalaš dieđut
Váldodahkkit: Aleksandra Berkan-Kawińska, Anna Piekarska, Hanna Berak, Włodzimierz Mazur, Aleksander Garlicki, Magdalena Tudrujek-Zdunek, Beata Lorenc, Dorota Dybowska, Łukasz Socha, Anna Parfieniuk-Kowerda, Robert Flisiak
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Termedia Publishing House 2024-07-01
Ráidu:Clinical & Experimental Hepatology
Fáttát:
hiv/hcv coinfection
daa treatment
glecaprevir/pibrentasvir
bictegravir/emtricitabine/tenofovir alafenamide
Liŋkkat:https://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.html
  • Oažžasuvvandieđut
  • Govvádus
  • Geahča maid
  • Bargiidšearbma

Interneahtta

https://www.termedia.pl/Effectiveness-of-glecaprevir-pibrentasvir-in-HIV-HCV-coinfected-patients-treated-with-bictegravir-emtricitabine-tenofovir-alafenamide,80,54512,1,1.html

Geahča maid

  • RP-HPLC method development and validation for the estimation of Emtricitabine, Bictegravir and Tenofovir alafenamide in bulk and pharmaceutical dosage form
    Dahkki: Tej Kumar Kokkirala, et al.
    Almmustuhtton: (2019-12-01)
  • Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
    Dahkki: Hernando Knobel, et al.
    Almmustuhtton: (2023-12-01)
  • Clinical efficacy, safety, and subjective experience based on ePRO in HIV‐infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China
    Dahkki: Linghong Kong, et al.
    Almmustuhtton: (2023-08-01)
  • Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
    Dahkki: Desmond Y. H. Yap, et al.
    Almmustuhtton: (2020-10-01)
  • Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study
    Dahkki: Lin Gan, et al.
    Almmustuhtton: (2024-06-01)

Ozu molssaeavttut

  • Ohcanhistorjá
  • Aiddostahtton ohcu

Viečča lasi

  • Bláđe logahallama
  • Bláđe alfabehtalaš ortnegis
  • Dutkka kanálaid
  • Gursagirjjit
  • Ođatlogahallan

Dárbbašatgo veahki?

  • Ohcanráva
  • Jeara girjerájus
  • DJG:t